Current through Register Vol. 50, No. 11, November 20, 2024
Section XIII-4515 - General ProvisionsA. The requirements of this Section shall not apply to the genetic information obtained: 1. by a state, parish, municipal, or federal law enforcement agency for the purposes of establishing the identity of a person in the course of a criminal investigation or prosecution;2. to determine paternity;3. to determine the identity of deceased individuals;4. for anonymous research where the identity of the subject will not be released because it is confidential;5. pursuant to newborn screening requirements established by state or federal law;6. as authorized by federal law for the identification of persons;7. by the Department of Social Services or by a court having juvenile jurisdiction as set forth in Children's CodeArticle 302 for the purposes of child protection investigations or neglect proceedings.8. For treatment, payment, and healthcare operations by an insurer consistent with the federal Health Insurance Portability and Accountability Act and its related regulations.9. For maintenance of information by an insurer in accordance with record retention requirements.B. An applicant/insured's genetic information is the property of the applicant/insured. No person shall retain genetic information without first obtaining authorization from the applicant/insured or a duly authorized representative, unless retention is: 1. for the purposes of a criminal or death investigation or criminal or juvenile proceeding;2. to determine paternity.C. For purposes of R.S. 22:1023, any person who acts without proper authorization to collect a DNA sample for analysis, or willfully discloses genetic information without obtaining permission from the individual or patient as required under this regulation, shall be liable to the individual for each such violation in an amount equal to: 1. any actual damages sustained as a result of the unauthorized collection, storage, analysis, or disclosure, or $50,000, whichever is greater;2. treble damages, in any case where such a violation resulted in profit or monetary gain;3. the costs of the action together with reasonable attorney fees as determined by the court, in the case of a successful action to enforce any liability under R.S. 22:1023.D. Any person who, either through a request, the use of persuasion, under threat, or under a promise of a reward, willfully induces another to collect, store or analyze a DNA sample in violation; or willfully collects, stores, or analyzes a DNA sample; or willfully discloses genetic information in violation of R.S. 22:1023 shall be liable to the individual for each such violation in an amount equal to: 1. any actual damages sustained as a result of the collection, analysis, or disclosure, or $100,000, whichever is greater;2. the costs of the action together with reasonable attorney fees as determined by the court, in the case of a successful action under R.S. 22:1023.E. The discrimination against an insured in the issuance, payment of benefits, withholding of coverage, cancellation, or nonrenewal of a policy, contract, plan or program based upon the results of a genetic test, receipt of genetic information, or a prenatal test other than one used for the determination of pregnancy shall be treated as an unfair or deceptive act or practice in the business of insurance under R.S. 22:1964.F. This regulation became effective June 20, 1998; however, the amendments to this regulation will become effective upon final publication in the Louisiana Register.La. Admin. Code tit. 37, § XIII-4515
Promulgated by the Department of Insurance, Commissioner of Insurance, LR 24:1122 (June 1998), Amended LR 46363 (3/1/2020).AUTHORITY NOTE: Promulgated in accordance with R.S. 22:11, 22:971, 22:258, 22:242(7), 22:1964(22) and (23), 22:1022, and 22:1023 of the Insurance Code.